Inflammation Systemic or chronic inflammation that impairs thyroid function and exacerbates thyroid disorders can stem from gut dysfunction
You inject once weekly into the abdomen, thigh, or upper arm using an insulin syringe
Saxenda uses a multiple-use auto-injector with individual, disposable needles
However, individual response timelines vary considerably, influenced by genetics, baseline metabolism, adherence, and dose titration schedules
One of the newest GLP-1s is called semaglutide
Promising new candidates include: Amycretin (Novo Nordisk) Orforglipron (Eli Lilly) Survodutide (Boehringer Ingelheim) VK2735 (Viking Therapeutics) MariTide (Amgen) Retatrutide (Eli Lilly) Among the most closely watched candidates is retatrutide, a triple-agonist developed by Eli Lilly that targets GLP-1, GIP, and glucagon receptors